McIntyre, Freedman & Flynn Investment Advisers’s Amgen AMGN Stock Holding History

McIntyre, Freedman & Flynn Investment Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$564K	Sell	1,557 -17	-1%	-$5.82K	0.34%	55
2026 Q1	$554K	Hold	1,574	–	–	0.31%	54
2025 Q4	$515K	Hold	1,574	–	–	0.32%	51
2025 Q3	$444K	Buy	1,574 +732	+87%	+$212K	0.27%	55
2025 Q2	$235K	Hold	842	–	–	0.17%	58
2025 Q1	$262K	Hold	842	–	–	0.19%	57
2024 Q4	$219K	Hold	842	–	–	0.16%	61
2024 Q3	$271K	Hold	842	–	–	0.19%	57
2024 Q2	$263K	Hold	842	–	–	0.19%	56
2024 Q1	$239K	Hold	842	–	–	0.17%	57
2023 Q4	$243K	Hold	842	–	–	0.19%	58
2023 Q3	$226K	Buy	+842	New	+$210K	0.19%	58
2023 Q2	–	Sell	-842	Closed	-$204K	–	62
2023 Q1	$204K	Hold	842	–	–	0.17%	57
2022 Q4	$221K	Buy	+842	New	+$226K	0.18%	59

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

McIntyre, Freedman & Flynn Investment Advisers's AMGN Position: Q2 2026 in Review

McIntyre, Freedman & Flynn Investment Advisers reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $5.82K and leaving 1,557 shares worth $564K. The position accounts for 0.34% of the portfolio, ranked #55.

McIntyre, Freedman & Flynn Investment Advisers first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 2,557 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

McIntyre, Freedman & Flynn Investment Advisers held 1,557 shares of Amgen worth $564K as of Q2 2026.
McIntyre, Freedman & Flynn Investment Advisers sold 17 Amgen shares in Q2 2026, an estimated $5.82K.
Amgen made up 0.34% of McIntyre, Freedman & Flynn Investment Advisers's portfolio in Q2 2026, its #55 holding.
McIntyre, Freedman & Flynn Investment Advisers first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
2,557 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on McIntyre, Freedman & Flynn Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.